Skip to main navigation Skip to search Skip to main content

A recombinant HAV expressing a neutralization epitope of HEV induces immune response against HAV and HEV in mice

  • Kui Xiang
  • , Yuri Kusov
  • , Guan Ying
  • , Wang Yan
  • , Yi Shan
  • , Wu Jinyuan
  • , Yin Na
  • , Zhou Yan
  • , Li Hongjun*
  • , Sun Maosheng
  • *Corresponding author for this work
  • Department of Molecular Biology
  • Chinese Academy of Medical Sciences
  • Department of Pathology
  • The Second Affiliated Hospital of Kunming Medical University
  • Airway Research Center North
  • Ltd.

Abstract

Hepatitis A virus (HAV) and hepatitis E virus (HEV) are causative agents of acute viral hepatitis transmitted via the fecal–oral route. Both viruses place a heavy burden on the public health and economy of developing countries. To test the possibility that HAV could be used as an expression vector for the development of a combination vaccine against hepatitis A and E infections, recombinant HAV-HEp148 was created as a vector to express an HEV neutralization epitope (HEp148) located at aa 459–606 of the HEV capsid protein. The recombinant virus expressed the HEp148 protein in a partially dimerized state in HAV-susceptible cells. Immunization with the HAV-HEp148 virus induced a strong HAV- and HEV-specific immune response in mice. Thus, the present study demonstrates a novel approach to the development of a combined hepatitis A and E vaccine.

Original languageEnglish
Article number260
JournalViruses
Volume9
Issue number9
DOIs
Publication statusPublished - 15.09.2017

Funding

Conflicts of Interest: No conflicting financial interests exist. This work was supported by grant (2016-I2M-1-019) from the CAMS Initiative for Innovative Medicine and Science and Technology Plan Project of Yunnan Province (2014BC008; 2016FB034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A recombinant HAV expressing a neutralization epitope of HEV induces immune response against HAV and HEV in mice'. Together they form a unique fingerprint.

Cite this